Revlimid (Lenalidomide)
Hi All,
Here is a study about Revlimid for patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q. Significantly more patients achieved red blood cell transfusion independence with lenalidomide 10 mg (56.1%) and 5 mg (42.6%) versus placebo (5.9%). http://bloodjournal.hematologylibrar...8/14/3757.full http://bloodjournal.hematologylibrar.../3765.abstract Kind regards Birgitta-A |
All times are GMT -4. The time now is 12:47 PM. |
Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
Forum sites may contain non-authoritative and unverified information.
Medical decisions should be made in consultation with qualified medical professionals.
Site contents exclusive of member posts Copyright © 2006-2020 Marrowforums.org